首页> 中文期刊> 《中国现代中药》 >日本汉方制剂说明书与我国中成药说明书对比浅析

日本汉方制剂说明书与我国中成药说明书对比浅析

         

摘要

This paper analyzed the drug instruction of Ethical kampo extract product in Japan and contrasted with the writing requirement of the drug instruction of Ethical New TCMs in China,the functions and indications in the drug instruction for the some prescription produced by different drug manufacturers are of more standard and uniform in China,but the safety information are more completed and unified in Japan.So in fact,it should not refer the functions and indications in the drug instruction of Kampo formulation for prescription in Japan but it is necessary to imitate the writing and updating experience of safety information for the classical representative famous prescriptions in China.%本文分析了日本医用汉方制剂说明书并与我国现行中成药处方药说明书撰写要求进行了对比,发现我国中成药处方药说明书在不同生产企业同品种说明书功能主治的表述上较日本汉方制剂更为规范统一,日本医用汉方制剂在不同生产企业同品种说明书的安全性信息表述上更为完整和统一.因此,在我国经典名方制剂说明书[功能主治]项不应参考日本医用汉方制剂的表述和管理方式,但是对于说明书中安全性信息的撰写和更新上可借鉴日本汉方制剂的相关经验.

著录项

相似文献

  • 中文文献
  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号